|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
8 August 2016 |
|
Main ID: |
NCT02415894 |
|
Date of registration:
|
02/04/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Ukraine
|
|
Scientific title:
|
Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy (13-22 Weeks LMP) in Ukraine |
|
Date of first enrolment:
|
April 2015 |
|
Target sample size:
|
172 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02415894 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Ukraine
| | | | | | | |
|
Contacts
|
|
Name:
|
Tamar Tsereteli, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Gynuity Health Projects |
|
|
Name:
|
Galina Maistruk, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Woman Health and Family Planning Charitable Foundation |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Having an ongoing pregnancy of 13-22 weeks gestation
- Be willing to undergo surgical completion if necessary
- Have no contraindications to study procedures, according to provider
- Be willing and able to consent to participate in the study
- Be willing to follow study procedures
Exclusion Criteria:
- Known allergy to mifepristone or misoprostol/prostaglandin
- Any contraindications to vaginal delivery, including placenta previa
- Unable to provide consent
Age minimum:
N/A
Age maximum:
N/A
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Other Abortion
|
|
Primary Outcome(s)
|
|
Rate of successful abortion
[Time Frame: 15 hours after start of misoprostol induction]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|